These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 33731936)

  • 1. Innovators target vaccines for variants and shortages in global South.
    Sheridan C
    Nat Biotechnol; 2021 Apr; 39(4):393-396. PubMed ID: 33731936
    [No Abstract]   [Full Text] [Related]  

  • 2. COVID-19 may become nanomedicine's finest hour yet.
    Friedrichs S; Bowman DM
    Nat Nanotechnol; 2021 Apr; 16(4):362-364. PubMed ID: 33854220
    [No Abstract]   [Full Text] [Related]  

  • 3. Special focus 'SARS-CoV-2 / COVID-19: advances in developing vaccines and immunotherapeutics'.
    Dhama K; Singh Malik Y; Rabaan AA; Rodriguez-Morales AJ
    Hum Vaccin Immunother; 2020 Dec; 16(12):2888-2890. PubMed ID: 33393853
    [No Abstract]   [Full Text] [Related]  

  • 4. Novavax offers first evidence that COVID vaccines protect people against variants.
    Callaway E; Mallapaty S
    Nature; 2021 Feb; 590(7844):17. PubMed ID: 33510489
    [No Abstract]   [Full Text] [Related]  

  • 5. How nano can fight the virus.
    Ball P
    Nat Mater; 2021 Feb; 20(2):126. PubMed ID: 33504984
    [No Abstract]   [Full Text] [Related]  

  • 6. [The Saga of Vaccines against Covid-19].
    Saliou P
    Bull Soc Pathol Exot; 2020; 113(4):185-186. PubMed ID: 33826275
    [No Abstract]   [Full Text] [Related]  

  • 7. Blunted humoral response after mRNA vaccine in patients with haematological malignancies.
    Kamboj M
    Lancet Haematol; 2021 Aug; 8(8):e540-e542. PubMed ID: 34224666
    [No Abstract]   [Full Text] [Related]  

  • 8. The Century of mRNA Vaccines: COVID-19 Vaccines and Allergy.
    Ortega Rodríguez NR; Audícana Berasategui MT; de la Hoz Caballer B; Valero Santiago A
    J Investig Allergol Clin Immunol; 2021 Feb; 31(1):89-91. PubMed ID: 33393485
    [No Abstract]   [Full Text] [Related]  

  • 9. [Vaccination immunology in SARS-CoV-2].
    Helweg-Larsen J; Benfield T
    Ugeskr Laeger; 2021 Mar; 183(11):. PubMed ID: 33734074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What Are COVID-19 Vaccines?
    Hartert TV; Sockrider M
    Am J Respir Crit Care Med; 2021 May; 203(9):P22-P23. PubMed ID: 33759735
    [No Abstract]   [Full Text] [Related]  

  • 11. COVID-19 vaccines and decreased transmission of SARS-CoV-2.
    Vitiello A; Ferrara F; Troiano V; La Porta R
    Inflammopharmacology; 2021 Oct; 29(5):1357-1360. PubMed ID: 34279767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New vaccine production platforms used in developing SARS-CoV-2 vaccine candidates.
    Ura T; Yamashita A; Mizuki N; Okuda K; Shimada M
    Vaccine; 2021 Jan; 39(2):197-201. PubMed ID: 33279318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Covid-19 vaccines and new mutant strains impacting the pandemic.
    Matta S; Rajpal S; Chopra KK; Arora VK
    Indian J Tuberc; 2021 Apr; 68(2):171-173. PubMed ID: 33845947
    [No Abstract]   [Full Text] [Related]  

  • 14. COVID-19 vaccines for patients with haematological conditions.
    Sun C; Pleyer C; Wiestner A
    Lancet Haematol; 2021 May; 8(5):e312-e314. PubMed ID: 33811822
    [No Abstract]   [Full Text] [Related]  

  • 15. Necessity of 2 Doses of the Pfizer and Moderna COVID-19 Vaccines.
    Livingston EH
    JAMA; 2021 Mar; 325(9):898. PubMed ID: 33533893
    [No Abstract]   [Full Text] [Related]  

  • 16. Messenger RNA vaccines against SARS-CoV-2.
    Topol EJ
    Cell; 2021 Mar; 184(6):1401. PubMed ID: 33740443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Achieving global equity for COVID-19 vaccines: Stronger international partnerships and greater advocacy and solidarity are needed.
    Figueroa JP; Hotez PJ; Batista C; Ben Amor Y; Ergonul O; Gilbert S; Gursel M; Hassanain M; Kang G; Kaslow DC; Kim JH; Lall B; Larson H; Naniche D; Sheahan T; Shoham S; Wilder-Smith A; Sow SO; Strub-Wourgaft N; Yadav P; Bottazzi ME
    PLoS Med; 2021 Sep; 18(9):e1003772. PubMed ID: 34516558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How to redesign COVID vaccines so they protect against variants.
    Callaway E; Ledford H
    Nature; 2021 Feb; 590(7844):15-16. PubMed ID: 33514888
    [No Abstract]   [Full Text] [Related]  

  • 19. Equitable global access to coronavirus disease 2019 vaccines.
    Schwartz JL
    BMJ; 2020 Dec; 371():m4735. PubMed ID: 33323384
    [No Abstract]   [Full Text] [Related]  

  • 20. Neutralizing SARS-CoV-2.
    Poeschla E
    Elife; 2020 Dec; 9():. PubMed ID: 33320086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.